Results 131 to 140 of about 76,581 (257)

Diagnostic and Therapeutic Potential of Substance P/NK1 Receptor in Primary Dysmenorrhea: A Pilot Study

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Primary dysmenorrhea is a prevalent condition that causes significant menstrual pain and discomfort, impacting many women′s daily activities. The Substance P/NK1 receptor (SP/NK1R) pathway has been linked to the pain mechanisms underlying dysmenorrhea, yet its potential as a therapeutic target remains inadequately explored.
Riffat Mehboob, Imran Shahid, Abdullah R. Alzahrani, Shimaa Mohammad Yousof, Hafsa Adnan, Samar N. Ekram, Ahmad Alwazzan, Hisham Nasief, Khalid A. Khadawardi   +8 more
wiley   +1 more source

Continuous use of gonadotropin-releasing hormone (GnRH)-agonist maintains high luteinizing hormone concentrations at the time of oocyte retrieval in women undergoing GnRH-agonist long protocol assisted reproductive technology treatment and stimulation with recombinant follicle-stimulating hormone [PDF]

, 2009
Shirei Ohgi, Koji Nakagawa, Akira Nakashima, Takashi Horikawa, Rikikazu Sugiyam, Hidekazu Saito   +5 more
openalex  

Urinary tract endometriosis: Revisiting the definition of ureterolysis

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 279-294, January 2026.
Abstract Objectives To report the incidence of urinary tract endometriosis (UTE) among patients with deep endometriosis, and to analyze surgical procedures, the rate of complications, and the recurrence rate in patients with UTE managed in a French expert center.
Constance Durant Des Aulnois, Léo Razakamanantsoa, Adrien Crestani, Ylan Abrahami, Steeve Doizi, Florie Gomez, Cyril Touboul, Isabelle Thomassin Naggara, Emile Daraï, Yohann Dabi   +9 more
wiley   +1 more source

Effect of adding gonadotropin-releasing hormone agonists for luteal support in antagonist cycles on pregnancy outcomes. [PDF]

Sci Rep
Du J, Liu C, Zheng Y, Zhou W, Han X, Wang H, Zhang X, Sun M, Li X.   +8 more
europepmc   +1 more source

Decreased Expression of A-Kinase Anchoring Protein 150 in GT1 Neurons Decreases Neuron Excitability and Frequency of Intrinsic Gonadotropin-Releasing Hormone Pulses [PDF]

, 2009
Qiumei Chen, Richard I. Weiner, Brigitte E. Blackman   +2 more
openalex   +1 more source

Review for "The electrophysiologic properties of gonadotropin‐releasing hormone neurons"

, 2021

openalex   +1 more source

Bifenthrin Under Scrutiny: Revisiting Toxicological Evidence Amid Regulatory Gaps

Journal of Applied Toxicology, Volume 46, Issue 1, Page 61-77, January 2026.
ABSTRACT Despite growing health concerns, bifenthrin (BF) remains widely used for controlling agricultural and residential pests. However, different perspectives on its toxicological profile and regulatory framework warrant a revisit and update on BF regulation towards a robust risk‐safety assessment.
Caroline V. L. Moreira, John Ogbu I, Kadja L. C. Monteiro, Thiago M. de Aquino, Edeildo F. da Silva‐Júnior, Alberto S. S. Filho, Hamilton B. Napolitano, Christianah A. Elusiyan, Renê O. do Couto, Elson A. Costa, James O. Fajemiroye   +10 more
wiley   +1 more source

Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment. [PDF]

PLoS One
Tanioka S, Asano R, Ota Y, Nagai K, Takenaka K, Mizushima T, Miyagi Y, Miyagi E.   +7 more
europepmc   +1 more source

Review for "Seasonal differences in hypothalamic thyroid‐stimulating hormone β, gonadotropin‐releasing hormone‐I and deiodinase expression between migrant and resident subspecies of white‐crowned sparrow ( Zonotrichia leucophrys )"

, 2021

openalex   +1 more source

Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention

MedComm, Volume 7, Issue 1, January 2026.
The review manuscript examines the molecular pathogenesis, screening, prevention advances, and evolving targeted therapies in breast cancer. It highlights the integration of AI and multiomics for precision prevention and personalized treatment, pointing toward future directions in equitable cancer care.
Huijun Lei, Jinzhen Fu, Wei Gu, Hongjin Qiao, Huixue Guo, Zijian Chen, San Ming Wang, Tianhui Chen   +7 more
wiley   +1 more source